-
62. SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AND COVID-19 INFECTION IN HEMODIALYSIS PATIENTS
I.Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , May 2021, Volume 36, Supplement 1
-
63. COVID-19 INFECTION IN HEMODIALYSIS PATIENTS:FINDINGS-EXPERIENCE-OUTCOME
I.Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , May 2021, Volume 36, Supplement 1
-
64. HEMOPERFUSION IN HEMODIALYSIS PATIENTS WITH COVID-19 INFECTION: IMPACT ON CLINICAL COURSE
I.Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , May 2021, Volume 36, Supplement 1
-
65. Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
Ioannis Griveas1 , Antonios Schoinas2 , Anthi Balitsari3 , Gerasimos Asimakopoulos4 , Evaggelos Pratilas5 1 Medical
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
ASIAN JOURNAL OF MEDICAL SCIENCES, July 2021
-
66. IgM and IgG antibody response to SARS-CoV-2 Infection and Viral RNA Persistence in hospitalized chronic kidney disease patients under Hemodialysis (HD)
Ioannis Grivea
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
ASIAN JOURNAL OF MEDICAL SCIENCES, July 2021
-
67. SmartPD™ Automated Peritoneal Dialysis System as a New Sophisticated Choice for Urgent Integration in Replacement Therapy for a Patient with ESRD
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.
JASN-SUPPELEMENT OCT 2021 FOR ASN-Renal week , San Diego , 4-7 November 2021
-
68. Effectiveness of hemoperfusion (HP) in hemodialysis (HD) patients with Covid-19 infection
Ioannis Griveas * Nephrology Department, Army Share Fund Hospital of Athens, 417 NIMTS, Greece
Transfusion and Apheresis Science 61( 28 October 2022)
-
69. Apheresis and Covid-19-Editorial
Ioannis Griveas * Nephrology Department, Army Share Fund Hospital of Athens, 417 NIMTS, Greece
Transfusion and Apheresis Science 61( 28 October 2022)
-
70. Immunoadsorption and covid 19 pandemic
Paraskevi Tseke a,* , Ioannis Griveas b
a General Hospital of Athens ALEXANDRA, Greece b Army Cher Fund Hospital of Athens, Greece
Transfusion and Apheresis Science 61( 28 October 2022)
-
71. Dialysis Patients Respond Adequately to Influenza Vaccination Irrespective of Dialysis Modality and Chronic Inflammation
Ioannis Griveas
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
J Clin Med . 2023 Sep 26;12(19):6205. doi: 10.3390/jcm12196205.
-
72. "Experience comparing the use of citric acid solution (CD) with L-ascorbic acid (Vitamin C) to simple citric solution in patients with End-Stage Renal Disease (ESRD) under hemodialysis (HD)."
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.
JASN -ASN-Renal week ,ASN-Renal Week , Philadelphia , 2-5 November 2023
-
73. Impact of Dapagliflozin on Anemia Status of patients with CKD
Ioannis Griveas
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.
JASN ASN-Renal Week , San Diego , 23-27 October 2024
-
74. Use of therapeutic apheresis methods during pregnancy
Ioannis Griveas
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
Transfus Apher Sci. 2024 Feb;63(1):103848. doi: 10.1016/j.transci.2023.103848. Epub 2023 Nov 15.
-
75. Therapeutic Apheresis and Nephrologist: New and old aspects
Ioannis Griveas
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
Transfus Apher Sci. 2024 Feb;63(1):103849. doi: 10.1016/j.transci.2023.103849. Epub 2023 Nov 20.
-
76. Use of Therapeutic Apheresis methods in Neurology patients
Ioannis Griveas
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
Transfus Apher Sci. 2024 Feb;63(1):103855. doi: 10.1016/j.transci.2023.103855. Epub 2023 Nov 24
